Launched in 2012, the multinational KATHERINE trial involved almost 1,500 women with HER2-positive breast cancer and residual disease in the breast or axillary lymph nodes after neoadjuvant ...
Hosted on MSN2mon
Phase III trial finds trastuzumab emtansine improves long-term survival in HER2 breast cancer"KATHERINE is a landmark clinical trial that found T-DM1 had such improved activity relative to trastuzumab that the results were reported earlier than had been anticipated when the study was ...
Key Abstracts in HER2-Positive Breast Cancer From SABCS 2023 Highlights in HER2+ breast cancer from SABCS 2023 include data from the HER2CLIMB-02 trial of ... up of the KATHERINE trial, as ...
Katherine Heigl has filed a defamation lawsuit ... In the JHF complaint the Heigls are insisting that the case be brought to trial before a jury.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback